Latest Profit Forecasts News

Harmoney Corp has delivered a record FY25 performance, exceeding profit expectations and boosting its FY26 profit forecast by 20%, driven by strong loan growth and its advanced Stellare 2.0 platform.

Ariadne Australia Limited anticipates a near breakeven total comprehensive income for FY25, balancing solid profits with significant portfolio losses and partnership costs.

SKS Technologies Group has exceeded its FY25 profit guidance, reporting a 15.6% increase in profit before tax alongside robust revenue growth and a strong cash position.

MONEYME has exceeded its FY25 operating cash profit expectations by 20%, driven by robust loan book expansion and improved credit quality, while gearing up for a major credit card launch.

Regal Partners Limited reported a 7% increase in funds under management to $17.7 billion for the June quarter, driven by strong inflows and investment gains. The company also upgraded its performance fee and profit forecasts for the first half of 2025.

Tourism Holdings Limited trims its FY25 profit guidance to the lower end of analyst expectations, citing ongoing challenges in global RV sales and a potential goodwill impairment tied to its US operations.

Cogstate Ltd has upgraded its FY25 financial guidance, projecting a 20-24% revenue increase and nearly doubling profit before tax compared to last year.

Cochlear Limited has lowered its FY25 earnings guidance due to slower-than-expected sales growth and a sharper decline in Services revenue. Despite this, implant unit growth remains on track, driven by emerging markets.

DGL Group projects a challenging FY25 with profits down sharply despite steady revenue, as it undertakes major cost realignment and operational integration to set the stage for future growth.

Powerhouse Ventures Limited has issued its first-ever cash profit guidance for FY25, signalling a pivotal shift towards self-sustaining operations backed by strong corporate advisory and treasury performances.

AFT Pharmaceuticals reported a 6% revenue increase to NZ$208 million in FY25, driven by strong ANZ growth and expanding international presence. The company targets NZ$300 million revenue by FY27 amid ongoing R&D and new product launches.

Monash IVF Group has lowered its full-year profit guidance for FY2025 to $27.5 million, citing weaker market conditions and ongoing impacts from a recent operational incident in Brisbane. The company remains cautious as it monitors patient trends and legal costs.